Suppression of Testosterone and Androstenedione Production Rates with Dexamethasone in Women with Idiopathic Hirsutism and Polycystic Ovaries
C. Wayne Bardin, Wylie C. Hembree, Mortimer B. Lipsett
Abstract
C. Wayne Bardin, Wylie C. Hembree, Mortimer B. Lipsett
Abstract
Testosterone and androstenedione plasma levels were measured in 7 normal women and 22 hirsute women with either idiopathic hirsutism (IH) or polycystic ovaries (PCO). During dexamethasone administration, plasma testosterone decreased 25% in normal subjects and 40–50% in the patients with IH and PCO. Plasma androstenedione levels were suppressed 40–55% in the normal and hirsute women. The mean testosterone metabolic clearance rate for 8 hirsute women increased 10 % during dexamethasone administration but there was no significant change in the androstpnedione metabolic clearance. Thus, the decrease in blood androgen levels produced by glucocorticoid was a consequence of decreased androgen production. These studies indicate further that a gland which is suppressed by dexamethasone is responsible for a significant fraction of the excess androgen production in women with either IH or PCO.
OpenAlex reports 78 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Testosterone and androstenedione plasma levels were measured in 7 normal women and 22 hirsute women with either idiopathic hirsutism (IH) or polycystic ovaries (PCO). During dexamethasone administration, plasma testosterone decreased 25% in normal subjects and 40–50% in the patients with IH and PCO. Plasma androstenedione levels were suppressed 40–55% in the normal and hirsute women. The mean testosterone metabolic clearance rate for 8 hirsute women increased 10 % during dexamethasone administration but there was no significant change in the androstpnedione metabolic clearance. Thus, the decrease in blood androgen levels produced by glucocorticoid was a consequence of decreased androgen production. These studies indicate further that a gland which is suppressed by dexamethasone is responsible for a significant fraction of the excess androgen production in women with either IH or PCO.
Key concepts: Androstenedione, hirsutism, Endocrinology, Internal medicine, Polycystic ovary, Testosterone (patch), Dexamethasone, Androgen